Artificial Intelligence • Finance Technology
Auditoria is an AI-powered finance company that automates business processes and improves cash performance for companies.
Biopharmaceutical • Clinical-stage
Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.
Biotechnology • Autoimmune therapies
Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.
Cybersecurity • SaaS platform
Zero Networks is a cybersecurity firm that offers a fully automated SaaS platform employing zero trust principles to restrict user and machine access to only necessary assets and facilitate secure remote connections.
Therapeutic Oncology • Solid Tumor Cancer Treatment
RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.
Biopharmaceutical • Antibody-Drug Conjugate (ADC) Development
MBrace Therapeutics is a biopharmaceutical company developing a lead antibody-drug conjugate (ADC) candidate, MBRC-101, targeting the EphA5 receptor tyrosine kinase present in various cancers, with the recent completion of an $85 million Series B financing round.